Who
Peter Fong
Director
Company insider
Files Form 4 as: Director, Rocket Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 24 Sep 2025
- Last trade
- 18 Jun 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —22,862 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —64,860 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —64,860 at $0.00 | filing |
| 18 Jun 2026filed 6 Jul 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —22,862 at $0.00 | filing |
| 24 Sep 2025filed 3 Oct 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —23,333 at $0.00 | filing |
| 24 Sep 2025filed 3 Oct 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.